Menu
← Oncology Approval Tracker
FDA DECISION ·
Bendamustine hydrochloride injection
bendamustine hydrochloride · Dr. Reddy’s Laboratories
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
For adults with CLL or with indolent B-cell non-Hodgkin lymphoma that progressed during or within 6 months after rituximab or a rituximab-containing regimen.
LAMPGEN ANALYSIS
Why it matters
FDA approved a separate bendamustine injection product under an original NDA for these established uses.
What research teams should watch
Use product-specific vial, dilution, and infusion instructions and preserve blood count and tumor lysis monitoring.
PRIMARY RECORDS